Institutional Investors Hold 7.56% of Imperial Tobacco Stocks

Business by 2FIRSTS.ai
Sep.25.2023
Institutional Investors Hold 7.56% of Imperial Tobacco Stocks
Valeo Financial Advisors LLC reduces its stake in British American Tobacco by 14.0% in Q2, according to SEC filings.

According to a report by dailypolitical on September 24th, Valeo Financial Advisors LLC disclosed in a recent filing with the US Securities and Exchange Commission that it reduced its holdings in British American Tobacco company by 14.0% in the second quarter. The fund sold 2,030 shares and now holds 12,422 shares of British American Tobacco. As of the end of the most recent quarter, the value of British American Tobacco shares held by Valeo Financial Advisors LLC was $412,000.

 

Investment firm Annual Investment Partners Limited Liability Company purchased approximately $25,000 worth of new shares in British American Tobacco Company in the third quarter. Sanctuary Wealth Management LLC acquired new shares in British American Tobacco Company valued at around $27,000 in the fourth quarter. GPS Wealth Strategies Group LLC invested in $28,000 worth of new shares in British American Tobacco Company in the first quarter. Motco significantly increased its stake in British American Tobacco Company by 1,025.4% during the fourth quarter. Motco bought an additional 687 shares during this period, currently holding 754 shares in the company worth $30,000. Lastly, Ahrens Investment Partners LLC bought new shares in British American Tobacco valued at $30,000 in the first quarter. Institutional investors hold 7.56% of Empire Tobacco stocks.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.